{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:06:31Z","timestamp":1793106391196,"version":"4.5.0"},"reference-count":130,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T00:00:00Z","timestamp":1703462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Inflammatory bowel disease is a set of chronic inflammatory diseases that mainly develop in the gastrointestinal mucosa, including ulcerative colitis and Crohn\u2019s disease. Gastrointestinal membrane permeability is an important factor influencing the pharmacological effects of pharmaceuticals administered orally for treating inflammatory bowel disease and other diseases. Understanding the presence or absence of changes in pharmacokinetic properties under a disease state facilitates effective pharmacotherapy. In this paper, we reviewed the gastrointestinal membrane function in ulcerative colitis and Crohn\u2019s disease from the perspective of in vitro membrane permeability and electrophysiological parameters. Information on in vivo permeability in humans is summarized. We also overviewed the inflammatory bowel disease research using gut-on-a-chip, in which some advances have recently been achieved. It is expected that these findings will be exploited for the development of therapeutic drugs for inflammatory bowel disease and the optimization of treatment options and regimens.<\/jats:p>","DOI":"10.3390\/pharmaceutics16010029","type":"journal-article","created":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T22:59:09Z","timestamp":1703545149000},"page":"29","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Intestinal Membrane Function in Inflammatory Bowel Disease"],"prefix":"10.3390","volume":"16","author":[{"given":"Daisuke","family":"Nakai","sequence":"first","affiliation":[{"name":"Drug Metabolism & Pharmacokinetics Research Laboratory, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masateru","family":"Miyake","sequence":"additional","affiliation":[{"name":"Pharmapack Co., Ltd., 1-27 Nakaokubo, Toyama 939-2243, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/17474124.2017.1343143","article-title":"The intestinal barrier: A fundamental role in health and disease","volume":"11","author":"Vancamelbeke","year":"2017","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: Regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3748\/wjg.v20.i5.1165","article-title":"Intestinal barrier in inflammatory bowel disease","volume":"20","author":"Antoni","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-020-2729-3","article-title":"Host\u2013microbiota maladaptation in colorectal cancer","volume":"585","author":"Janney","year":"2020","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1136\/gutjnl-2022-327365","article-title":"A mechanism by which gut microbiota elevates permeability and inflammation in obese\/diabetic mice and human gut","volume":"72","author":"Mishra","year":"2023","journal-title":"Gut"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1038\/s41467-019-12476-z","article-title":"Interplay between the human gut microbiome and host metabolism","volume":"10","author":"Visconti","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","article-title":"Leaky gut: Mechanisms, measurement and clinical implications in humans","volume":"68","author":"Camilleri","year":"2019","journal-title":"Gut"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1139821","DOI":"10.3389\/fimmu.2023.1139821","article-title":"Emerging roles of the gut microbiota in cancer immunotherapy","volume":"14","author":"Shi","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Imbrizi, M., Magro, F., and Coy, C.S.R. (2023). Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years. Pharmaceuticals, 16.","DOI":"10.3390\/ph16091272"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s10620-014-3437-3","article-title":"Environmental Factors in the Relapse and Recurrence of Inflammatory Bowel Disease: A Review of the Literature","volume":"60","author":"Martin","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bretto, E., Ribaldone, D.G., Caviglia, G.P., Saracco, G.M., Bugianesi, E., and Frara, S. (2023). Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies. Biomedicines, 11.","DOI":"10.3390\/biomedicines11082249"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2019.04.016","article-title":"Environmental risk factors for inflammatory bowel diseases: An umbrella review of Meta-analyses","volume":"157","author":"Piovani","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1097\/MIB.0000000000000080","article-title":"Fibrosis in ulcerative colitis\u2014Mechanisms, features and consequences of a neglected problem","volume":"20","author":"Gordon","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/00365521.2014.968863","article-title":"Mechanisms of initiation and progression of intestinal fibrosis in IBD","volume":"50","author":"Latella","year":"2015","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Elzayat, H., Mesto, G., and Al-Marzooq, F. (2023). Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases. Nutrients, 15.","DOI":"10.3390\/nu15153377"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Hesampour, F., Bernstein, C.N., and Ghia, J.E. (2023). Brain-Gut Axis: Invasive and Noninvasive Vagus Nerve Stimulation, Limitations, and Potential Therapeutic Approaches. Inflamm. Bowel Dis., izad211.","DOI":"10.1093\/ibd\/izad211"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1007\/s00253-023-12789-6","article-title":"The link between the gut microbiome, inflammation, and Parkinson\u2019s disease","volume":"107","author":"Nie","year":"2023","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"He, Y., Cheng, M., Yang, R., Li, H., Lu, Z., Jin, Y., Feng, J., and Tu, L. (2023). Research Progress on the Mechanism of Nanoparticles Crossing the Intestinal Epithelial Cell Membrane. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15071816"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"717925","DOI":"10.3389\/fnut.2021.717925","article-title":"The Role of Intestinal Permeability in Gastrointestinal Disorders and Current Methods of Evaluation","volume":"8","author":"Vanuytsel","year":"2021","journal-title":"Front. Nutr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/17474124.2023.2242772","article-title":"A spotlight on intestinal permeability and inflammatory bowel diseases","volume":"17","author":"Rath","year":"2023","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Meoli, L., and G\u00fcnzel, D. (2020). Channel functions of claudins in the organization of biological systems. Biochim. Biophys. Acta Biomembr., 1862.","DOI":"10.1016\/j.bbamem.2020.183344"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s11845-020-02490-2","article-title":"Review of claudin proteins as potential biomarkers for necrotizing enterocolitis","volume":"190","author":"Griffiths","year":"2021","journal-title":"Ir. J. Med. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41575-023-00766-3","article-title":"Paracellular permeability and tight junction regulation in gut health and disease","volume":"20","author":"Horowitz","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/cphy.c110045","article-title":"Claudins and other tight junction proteins","volume":"2","author":"Gunzel","year":"2012","journal-title":"Compr. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1152\/physrev.00019.2012","article-title":"Claudins and the modulation of tight junction permeability","volume":"93","author":"Gunzel","year":"2013","journal-title":"Physiol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tibs.2018.09.008","article-title":"The claudins: From tight junctions to biological systems","volume":"44","author":"Tsukita","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00424-016-1909-3","article-title":"Claudins: Vital partners in transcellular and paracellular transport coupling","volume":"469","author":"Gunzel","year":"2017","journal-title":"Pflugers Arch."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"12037","DOI":"10.1074\/jbc.M109.064808","article-title":"Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity","volume":"285","author":"Weber","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.chom.2017.05.009","article-title":"IL-22 upregulates epithelial claudin-2 to drive diarrhea and enteric pathogen clearance","volume":"21","author":"Tsai","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","article-title":"Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution","volume":"129","author":"Heller","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Monaco, A., Ovryn, B., Axis, J., and Amsler, K. (2021). The Epithelial Cell Leak Pathway. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147677"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Tervonen, A., Ihalainen, T.O., Nymark, S., and Hyttinen, J. (2019). Structural dynamics of tight junctions modulate the properties of the epithelial barrier. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0214876"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI24970","article-title":"Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo","volume":"115","author":"Clayburgh","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41591-019-0393-7","article-title":"Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis","volume":"25","author":"Graham","year":"2019","journal-title":"Nat. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semcdb.2015.04.003","article-title":"Claudin switching: Physiological plasticity of the Tight Junction","volume":"42","author":"Capaldo","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/nyas.13360","article-title":"Intestinal epithelial claudins: Expression and regulation in homeostasis and inflammation","volume":"1397","author":"Quiros","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Capaldo, C.T. (2023). Claudin Barriers on the Brink: How Conflicting Tissue and Cellular Priorities Drive IBD Pathogenesis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108562"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1242\/jcs.00165","article-title":"Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells","volume":"115","author":"Amasheh","year":"2002","journal-title":"J. Cell Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/labinvest.3700316","article-title":"Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells","volume":"85","author":"Prasad","year":"2005","journal-title":"Lab. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/labinvest.2008.78","article-title":"Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation","volume":"88","author":"Weber","year":"2008","journal-title":"Lab. Investig."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1111\/j.1440-1746.2008.05405.x","article-title":"Changes in the expression of claudins in active ulcerative colitis","volume":"23","author":"Oshima","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1007\/s10620-011-1688-9","article-title":"Increase in the tight junction protein claudin-1 in intestinal inflammation","volume":"56","author":"Poritz","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/gut.2006.094375","article-title":"Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn\u2019s disease","volume":"56","author":"Zeissig","year":"2007","journal-title":"Gut"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/00365521.2012.741616","article-title":"Expression profiling of claudins in the human gastrointestinal tract in health and during inflammatory bowel disease","volume":"48","author":"Lameris","year":"2013","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00384-009-0653-y","article-title":"Expression of tight and adherens junction proteins in ulcerative colitis associated colorectal carcinoma: Upregulation of claudin-1, claudin-3, claudin-4, and beta-catenin","volume":"24","author":"Mees","year":"2009","journal-title":"Int. J. Color. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Anderson, J.M., and Van Itallie, C.M. (2009). Physiology and function of the tight junction. Cold Spring Harb. Perspect. Biol., 1.","DOI":"10.1101\/cshperspect.a002584"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrm.2016.80","article-title":"Tight junctions: From simple barriers to multifunctional molecular gates","volume":"17","author":"Zihni","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00428-012-1195-1","article-title":"Comparative tight junction protein expressions in colonic Crohn\u2019s disease, ulcerative colitis, and tuberculosis: A new perspective","volume":"460","author":"Das","year":"2012","journal-title":"Virchows Arch."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yexcr.2017.03.061","article-title":"Interplay between tight junctions & adherens junctions","volume":"358","author":"Campbell","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e2217561120","DOI":"10.1073\/pnas.2217561120","article-title":"Cholesterol-rich domain formation mediated by ZO proteins is essential for tight junction formation","volume":"120","author":"Shigetomi","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Saib, S., and Delavenne, X. (2021). Inflammation Induces Changes in the Functional Expression of P-gp, BCRP, and MRP2: An Overview of Different Models and Consequences for Drug Disposition. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13101544"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ibd.20030","article-title":"Efflux transporters in ulcerative colitis: Decreased expression of BCRP (ABCG2) and Pgp (ABCB1)","volume":"13","author":"Englund","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000179361","article-title":"Breast cancer resistance protein and P-glycoprotein expression in patients with newly diagnosed and therapy-refractory ulcerative colitis compared with healthy controls","volume":"78","author":"Gutmann","year":"2008","journal-title":"Digestion"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.xphs.2018.09.024","article-title":"Dysregulation of Mucosal Membrane Transporters and Drug-Metabolizing Enzymes in Ulcerative Colitis","volume":"108","author":"Erdmann","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"122282","DOI":"10.1016\/j.ijpharm.2022.122282","article-title":"The impact of inflammation on the expression of drug transporters and metabolic enzymes in colonic tissue from ulcerative colitis patients","volume":"628","author":"Handin","year":"2022","journal-title":"Int. J. Pharm."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1053\/gast.2001.24845","article-title":"Colonic epithelial PepT1 expression occurs in inflammatory bowel disease: Transport of bacterial peptides influences expression of MHC class 1 molecules","volume":"120","author":"Merlin","year":"2001","journal-title":"Gastroenterology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1124\/dmd.109.027367","article-title":"Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients","volume":"37","author":"Wojtal","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"105075","DOI":"10.1016\/j.phrs.2020.105075","article-title":"Inflammatory Bowel Disease\u2014Non-biological treatment","volume":"160","author":"Magro","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/apt.15771","article-title":"Review article: Withdrawal of 5-aminosalicylates in inflammatory bowel disease","volume":"52","author":"Chapman","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1248\/bpb.b17-00181","article-title":"Inhibitory Potency of Marketed Drugs for Ulcerative Colitis and Crohn\u2019s Disease on PEPT1","volume":"40","author":"Miyake","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"16099","DOI":"10.1074\/jbc.M115.659318","article-title":"MicroRNA-193a-3p Reduces Intestinal Inflammation in Response to Microbiota via Down-regulation of Colonic PepT1","volume":"290","author":"Dai","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1124\/dmd.110.034991","article-title":"Role of organic anion-transporting polypeptides for cellular mesalazine (5-aminosalicylic acid) uptake","volume":"39","author":"Glaeser","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Moran, J.C., Huang, H., Rivas, M., Kaplan, J.L., Daly, M.J., and Winter, H.S. (2018). Genetic variants in cellular transport do not affect mesalamine response in ulcerative colitis. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0192806"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1002\/jps.23609","article-title":"Establishment of novel prediction system of intestinal absorption in humans using human intestinal tissues","volume":"102","author":"Miyake","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Arnold, Y.E., Thorens, J., Bernard, S., and Kalia, Y.N. (2019). Drug Transport across Porcine Intestine Using an Ussing Chamber System: Regional Differences and the Effect of P-Glycoprotein and CYP3A4 Activity on Drug Absorption. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11030139"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"C423","DOI":"10.1152\/ajpcell.00348.2015","article-title":"Beyond Ussing\u2019s chambers: Contemporary thoughts on integration of transepithelial transport","volume":"310","author":"Herrmann","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/ibd\/izz328","article-title":"Increased colonic epithelial permeability and mucosal eosinophilia in ulcerative colitis in remission compared with irritable Bowel syndrome and health","volume":"26","author":"Katinios","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.xphs.2019.12.015","article-title":"Comparison of the Intestinal Drug Permeation and Accumulation Between Normal Human Intestinal Tissues and Human Intestinal Tissues with Ulcerative Colitis","volume":"109","author":"Nakai","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/00498254.2016.1229085","article-title":"Effect of proinflammatory cytokine IL-6 on efflux transport of rebamipide in Caco-2 cells","volume":"47","author":"Miyake","year":"2017","journal-title":"Xenobiotica"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"G420","DOI":"10.1152\/ajpgi.00411.2017","article-title":"Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn\u2019s disease","volume":"315","author":"Libertucci","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Biskou, O., Meira de-Faria, F., Walter, S.M., Winberg, M.E., Haapaniemi, S., Myrelid, P., S\u00f6derholm, J.D., and Keita, \u00c5.V. (2022). Increased Numbers of Enteric Glial Cells in the Peyer\u2019s Patches and Enhanced Intestinal Permeability by Glial Cell Mediators in Patients with Ileal Crohn\u2019s Disease. Cells, 11.","DOI":"10.3390\/cells11030335"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/00365521.2018.1458146","article-title":"Infliximab restores colonic barrier to adherent-invasive E. coli in Crohn\u2019s disease via effects on epithelial lipid rafts","volume":"53","author":"Yakymenko","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1749-6632.2000.tb05259.x","article-title":"Epithelial barrier and transport function of the colon in ulcerative colitis","volume":"915","author":"Schmitz","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_76","first-page":"381","article-title":"Ulcerative colitis patients in remission have an altered secretory capacity in the proximal colon despite macroscopically normal mucosa","volume":"24","author":"Gustafsson","year":"2012","journal-title":"Neuro Gastroenterol. Motil."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1053\/gast.2001.29694","article-title":"Epithelial barrier defects in ulcerative colitis: Characterization and quantification by electrophysiological imaging","volume":"121","author":"Gitter","year":"2001","journal-title":"Gastroenterology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jphs.2022.07.006","article-title":"The change of the electrophysiological parameters using human intestinal tissues from ulcerative colitis and Crohn\u2019s disease","volume":"150","author":"Nakai","year":"2022","journal-title":"J. Pharmacol. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Hu, J.C.E., Wei\u00df, F., Bojarski, C., Branchi, F., Schulzke, J.D., Fromm, M., and Krug, S.M. (2021). Expression of tricellular tight junction proteins and the paracellular macromolecule barrier are recovered in remission of ulcerative colitis. BMC Gastroenterol., 21.","DOI":"10.1186\/s12876-021-01723-7"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Higashi, T., and Chiba, H. (2020). Molecular organization, regulation and function of tricellular junctions. Biochim. Biophys. Acta Biomembr., 1862.","DOI":"10.1016\/j.bbamem.2019.183143"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Awad, K., Barmeyer, C., Bojarski, C., Nagel, O., Lee, I.-F.M., Schweiger, M.R., Schulzke, J.D., and B\u00fccker, R. (2023). Impaired Intestinal Permeability of Tricellular Tight Junctions in Patients with Irritable Bowel Syndrome with Mixed Bowel Habits (IBS-M). Cells, 12.","DOI":"10.3390\/cells12020236"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Park, Y.S., Kang, S.B., Marchelletta, R.R., Penrose, H.M., Ruiter-Visser, R., Jung, B., Docherty, M.J., Boland, B.S., Sandborn, W.J., and McCole, D.F. (2023). The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn\u2019s Disease but Not Ulcerative Colitis Patients. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15030811"},{"key":"ref_83","first-page":"770","article-title":"Measurement of intestinal permeability using 51Cr-EDTA","volume":"80","author":"Peled","year":"1985","journal-title":"Am. J. Gastroenterol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/gut.35.1.68","article-title":"Intestinal permeability in patients with Crohn\u2019s disease and ulcerative colitis and their first degree relatives","volume":"35","author":"Munkholm","year":"1994","journal-title":"Gut"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"G919","DOI":"10.1152\/ajpgi.00168.2011","article-title":"Urine sugars for in vivo gut permeability: Validation and comparisons in irritable bowel syndrome-diarrhea and controls","volume":"301","author":"Rao","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1002\/ibd.22909","article-title":"Increased Small Intestinal Permeability in Ulcerative Colitis: Rather Genetic than Environmental and a Risk Factor for Extensive Disease?","volume":"18","author":"Geissler","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0022-3476(98)70145-3","article-title":"The sugar permeability test reflects disease activity in children and adolescents with inflammatory bowel disease","volume":"133","author":"Miki","year":"1998","journal-title":"J. Pediatr."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cca.2014.12.040","article-title":"Simultaneous gas-chromatographic urinary measurement of sugar probes to assess intestinal permeability: Use of time course analysis to optimize its use to assess regional gut permeability","volume":"442","author":"Shaikh","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2472754","DOI":"10.1155\/2019\/2472754","article-title":"Intestinal Permeability Measured by Urinary Sucrose Excretion Correlates with Serum Zonulin and Faecal Calprotectin Concentrations in UC Patients in Remission","volume":"2019","author":"Wegh","year":"2019","journal-title":"J. Nutr. Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1053\/j.gastro.2020.08.005","article-title":"Increased Intestinal Permeability Is Associated with Later Development of Crohn\u2019s Disease","volume":"159","author":"Turpin","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ng.717","article-title":"Genome-wide meta-analysis increases to 71 the number of confirmed Crohn\u2019s disease susceptibility loci","volume":"42","author":"Franke","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ng.764","article-title":"Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47","volume":"43","author":"Anderson","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.3748\/wjg.v29.i28.4368","article-title":"Microbiota revolution: How gut microbes regulate our lives","volume":"29","author":"Colella","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Foley, S.E., Tuohy, C., Dunford, M., Grey, M.J., De Luca, H., Cawley, C., Szabady, R.L., Maldonado-Contreras, A., Houghton, J.M., and Ward, D.V. (2021). Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis. Microbiome, 9.","DOI":"10.1186\/s40168-021-01137-3"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Brinar, M., Cukovic-Cavka, S., Bozina, N., Ravic, K.G., Markos, P., Ladic, A., Cota, M., Krznaric, Z., and Vucelic, B. (2013). MDR1 polymorphisms are associated with inflammatory bowel disease in a cohort of Croatian IBD patients. BMC Gastroenterol., 13.","DOI":"10.1186\/1471-230X-13-57"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1086\/379927","article-title":"MDR1 Ala893 polymorphism is associated with inflammatory bowel disease","volume":"73","author":"Brant","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.4049\/jimmunol.161.10.5733","article-title":"A novel model of inflammatory bowel disease: Mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis","volume":"161","author":"Panwala","year":"1998","journal-title":"J. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1385\/IR:31:2:151","article-title":"The mdr1a\u2212\/\u2212 mouse model of spontaneous colitis: A relevant and appropriate animal model to study inflammatory bowel disease","volume":"31","author":"Wilk","year":"2005","journal-title":"Immunol. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"G153","DOI":"10.1152\/ajpgi.00395.2004","article-title":"Epithelial dysfunction associated with the development of colitis in conventionally housed mdr1a\u2212\/\u2212 mice","volume":"289","author":"Smitham","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1217111","DOI":"10.3389\/fphar.2023.1217111","article-title":"Sinapic acid alleviates inflammatory bowel disease (IBD) through localization of tight junction proteins by direct binding to TAK1 and improves intestinal microbiota","volume":"14","author":"Jang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Guo, W., Tang, X., Zhang, Q., Zhao, J., Mao, B., Zhang, H., and Cui, S. (2023). Mitigation of Dextran-Sodium-Sulfate-Induced Colitis in Mice through Oral Administration of Microbiome-Derived Inosine and Its Underlying Mechanisms. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241813852"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Zheng, J., Ahmad, A.A., Yang, Y., Liang, Z., Shen, W., Feng, M., Shen, J., Lan, X., and Ding, X. (2022). Lactobacillus rhamnosus CY12 Enhances Intestinal Barrier Function by Regulating Tight Junction Protein Expression, Oxidative Stress, and Inflammation Response in Lipopolysaccharide-Induced Caco-2 Cells. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911162"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Vernia, F., Valvano, M., Longo, S., Cesaro, N., Viscido, A., and Latella, G. (2022). Vitamin D in inflammatory bowel diseases. mechanisms of action and therapeutic implications. Nutrients, 14.","DOI":"10.3390\/nu14020269"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3389\/fimmu.2018.01212","article-title":"Effector T helper cell subsets in inflammatory bowel diseases","volume":"9","author":"Imam","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ajpath.2023.02.004","article-title":"Vitamin D and Microbiome: Molecular Interaction in Inflammatory Bowel Disease Pathogenesis","volume":"193","author":"Aggeletopoulou","year":"2023","journal-title":"Am. J. Pathol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-230X-12-57","article-title":"Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice","volume":"12","author":"Zhao","year":"2012","journal-title":"BMC Gastroenterol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.3390\/nu7043011","article-title":"Vitamin D and 1,25(OH)2D regulation of T cells","volume":"7","author":"Cantorna","year":"2015","journal-title":"Nutrients"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3945\/ajcn.115.123786","article-title":"Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis","volume":"104","author":"Meckel","year":"2016","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/00365521.2020.1844793","article-title":"Clinical evaluation of vitamin D status and its relationship with disease activity and changes of intestinal immune function in patients with Crohn\u2019s disease in the Chinese population","volume":"56","author":"Yang","year":"2021","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/00365521.2016.1185463","article-title":"Vitamin D regulates the tight-junction protein expression in active ulcerative colitis","volume":"51","author":"Stio","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"103136","DOI":"10.1016\/j.autrev.2022.103136","article-title":"Molecular basis of vitamin D action in inflammatory bowel disease","volume":"21","author":"Triantos","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Szymczak-Tomczak, A., Ratajczak, A.E., Kaczmarek-Ry\u015b, M., Hryhorowicz, S., Rychter, A.M., Zawada, A., S\u0142omski, R., Dobrowolska, A., and Krela-Ka\u017amierczak, I. (2022). Pleiotropic effects of vitamin D in patients with inflammatory bowel diseases. J. Clin. Med., 11.","DOI":"10.3390\/jcm11195715"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41564-017-0072-8","article-title":"Enterotypes in the landscape of gut microbial community composition","volume":"3","author":"Costea","year":"2018","journal-title":"Nat. Microbiol."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Starz, E., Wzorek, K., Folwarski, M., Ka\u017amierczak-Siedlecka, K., Stachowska, L., Przew\u0142\u00f3cka, K., Stachowska, E., and Skonieczna-\u017bydecka, K. (2021). The modification of the gut microbiota via selected specific diets in patients with Crohn\u2019s disease. Nutrients, 13.","DOI":"10.3390\/nu13072125"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1365-2036.2005.02506.x","article-title":"Personal view: Food for thought\u2014Western lifestyle and susceptibility to Crohn\u2019s disease. The FODMAP hypothesis","volume":"21","author":"Gibson","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00394-021-02755-1","article-title":"FODMAPs, inflammatory bowel disease and gut microbiota: Updated overview on the current evidence","volume":"61","author":"Maganinho","year":"2022","journal-title":"Eur. J. Nutr."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1089\/jmf.2017.0120","article-title":"Inflammatory bowel diseases and fermentable oligosaccharides, disaccharides, monosaccharides, and polyols: An overview","volume":"21","author":"Barbalho","year":"2018","journal-title":"J. Med. Food"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.clnu.2017.05.019","article-title":"Is a low FODMAP diet beneficial for patients with inflammatory bowel disease? A meta-analysis and systematic review","volume":"37","author":"Zhan","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/jgh.13695","article-title":"Use of the low-FODMAP diet in inflammatory bowel disease","volume":"32","author":"Gibson","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jgh.13349","article-title":"A low FODMAP diet in patients with Crohn\u2019s disease","volume":"31","author":"Halmos","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: A randomized clinical trial","volume":"321","author":"Costello","year":"2019","journal-title":"JAMA"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","article-title":"Gut microbiota and IBD: Causation or correlation?","volume":"14","author":"Ni","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Zietek, T., Boomgaarden, W.A.D., and Rath, E. (2021). Drug Screening, Oral Bioavailability and Regulatory Aspects: A Need for Human Organoids. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13081280"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"20417314221149882","DOI":"10.1177\/20417314221149882","article-title":"Gut-on-a-chip for disease models","volume":"14","author":"Xian","year":"2023","journal-title":"J. Tissue Eng."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"62","DOI":"10.12688\/openreseurope.13709.2","article-title":"The translational roadmap of the gut models, focusing on gut-on-chip","volume":"1","author":"Malaguarnera","year":"2023","journal-title":"Open Res. Eur."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.celrep.2019.04.001","article-title":"Integrated In Vitro and In Silico Modeling Delineates the Molecular Effects of a Synbiotic Regimen on Colorectal-Cancer-Derived Cells","volume":"27","author":"Greenhalgh","year":"2019","journal-title":"Cell Rep."},{"key":"ref_128","first-page":"433","article-title":"Sprayable nanomicelle hydrogels and inflammatory bowel disease patient cell chips for development of intestinal lesion-specific therapy","volume":"18","author":"Yoon","year":"2022","journal-title":"Bioact. Mater."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"9999925","DOI":"10.1155\/2022\/9999925","article-title":"Fecal microbiota transplants for inflammatory bowel disease treatment: Synthetic- and engineered communities-based microbiota transplants are the future","volume":"2022","author":"Khan","year":"2022","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tifs.2023.03.006","article-title":"Microfluidic intestine-on-a-chip: Current progress and further perspectives of probiotic-foodborne pathogen interactions","volume":"134","author":"Xiang","year":"2023","journal-title":"Trends Food Sci. Technol."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/1\/29\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:41:38Z","timestamp":1760132498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/1\/29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,25]]},"references-count":130,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["pharmaceutics16010029"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics16010029","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,25]]}}}